| |
| |
|
| Insider
Information: |
Byrnes Michael |
| Relationship: |
Chief Financial Officer |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
43,271 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
43,271 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ocera Therapeutics Inc |
OCRX |
CFO and Treasurer |
2017-12-11 |
0 |
|
0 |
Premium* |
|
|
Effector Therapeutics Ord Shs |
EFTR |
Chief Financial Officer |
2023-11-15 |
43,271 |
2022-05-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EFTR |
Effector Therapeutics Ord... |
Chief Financial Officer |
• – – |
2023-11-15 |
4 |
A |
$0.50 |
$2,250 |
D/D |
4,524 |
43,271 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Chief Financial Officer |
• – – |
2023-05-15 |
4 |
A |
$0.46 |
$2,232 |
D/D |
4,863 |
38,747 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Chief Financial Officer |
• – – |
2022-11-15 |
4 |
A |
$0.47 |
$2,179 |
D/D |
4,651 |
33,884 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Chief Financial Officer |
• – – |
2022-06-07 |
4 |
B |
$1.33 |
$33,263 |
D/D |
25,000 |
29,233 |
2.74 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Chief Financial Officer |
• – – |
2022-05-13 |
4 |
A |
$1.53 |
$6,476 |
D/D |
4,233 |
4,233 |
0 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
CFO and Treasurer |
• – – |
2017-12-11 |
4 |
D |
$1.52 |
$247,760 |
D/D |
(163,000) |
0 |
0 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
CFO and Treasurer |
• – – |
2017-03-29 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
163,000 |
0 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
CFO and Treasurer |
• – – |
2017-03-28 |
4 |
B |
$1.28 |
$3,854 |
D/D |
3,000 |
13,000 |
2.66 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
CFO and Treasurer |
• – – |
2016-01-15 |
4 |
B |
$2.07 |
$7,245 |
D/D |
3,500 |
10,000 |
2.74 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
CFO and Treasurer |
• – – |
2015-05-06 |
4 |
B |
$3.61 |
$9,025 |
D/D |
2,500 |
6,500 |
2.74 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
VP, Finance & Treasurer |
• – – |
2014-10-01 |
4 |
B |
$4.81 |
$9,620 |
D/D |
2,000 |
4,000 |
2.74 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
VP, Finance & TreasurerOfficer |
• – – |
2014-09-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,000 |
|
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
